august 24 2025 glp-1 Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss GLP-1 Pipeline Update: November 2025

This issue of the HPCs DataPoints series explores trends in GLP-1 prescriptions in Massachusetts through September 2023 and examines the use and spending impacts of these drugs in the Commonwealth.

Power Up and Reset: Berberine Patch &amp

Advanced technology that provides you with easy access to the best doctors that you trust.

Nonalcoholic fatty liver disease (NAFLD) is a prevalent metabolic liver disease closely associated with the epidemics of obesity and type 2 diabetes mellitus (T2DM), but without licensed pharmacological treatment to date

for various self-reported benefits, including sleep improvement

To get the most out of GLP-1 medications, its important to follow a diet that complements their effects while supporting your overall health